These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1981710)

  • 1. Absorption of a novel prodrug of L-dopa, L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine (NB-355). In vitro and in situ studies.
    Hisaka A; Kasamatsu S; Takenaga N; Ohtawa M
    Drug Metab Dispos; 1990; 18(5):621-5. PubMed ID: 1981710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NB-355: a novel prodrug for L-DOPA with reduced risk for peak-dose dyskinesias in MPTP-treated squirrel monkeys.
    Tye SJ; Rupniak NM; Naruse T; Miyaji M; Iversen SD
    Clin Neuropharmacol; 1989 Oct; 12(5):393-403. PubMed ID: 2611764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new potential prodrug to improve the duration of L-dopa: L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine.
    Ihara M; Tsuchiya Y; Sawasaki Y; Hisaka A; Takehana H; Tomimoto K; Yano M
    J Pharm Sci; 1989 Jul; 78(7):525-9. PubMed ID: 2778650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluations of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318. Roles of efflux and metabolism.
    Prueksaritanont T; DeLuna P; Gorham LM; Ma B; Cohn D; Pang J; Xu X; Leung K; Lin JH
    Drug Metab Dispos; 1998 Jun; 26(6):520-7. PubMed ID: 9616186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the intestinal absorption of an ester-type prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug.
    Okudaira N; Tatebayashi T; Speirs GC; Komiya I; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Aug; 294(2):580-7. PubMed ID: 10900235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pGlu-L-Dopa-Pro: a tripeptide prodrug targeting the intestinal peptide transporter for absorption and tissue enzymes for conversion.
    Bai JP
    Pharm Res; 1995 Jul; 12(7):1101-4. PubMed ID: 7494810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease.
    Camargo SM; Vuille-dit-Bille RN; Mariotta L; Ramadan T; Huggel K; Singer D; Götze O; Verrey F
    J Pharmacol Exp Ther; 2014 Oct; 351(1):114-23. PubMed ID: 25073474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis and acyl migration of a catechol monoester of L-dopa: L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine.
    Ihara M; Nakajima S; Hisaka A; Tsuchiya Y; Sakuma Y; Suzuki H; Kitani K; Yano M
    J Pharm Sci; 1990 Aug; 79(8):703-8. PubMed ID: 2231333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of aerobic energy deficit, ouabain and harmaline on the phenylalanine and galactose active transport by snail intestine.
    Barber A; Bernabé S; San Juan N; Ponz F
    Rev Esp Fisiol; 1986 Dec; 42(4):517-23. PubMed ID: 3563077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of human intestinal absorption of the prodrug temocapril by in situ single-pass perfusion using rat intestine with modified hydrolase activity.
    Nozawa T; Imai T
    Drug Metab Dispos; 2011 Jul; 39(7):1263-9. PubMed ID: 21474683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
    Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
    Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine.
    Okudaira N; Komiya I; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Nov; 295(2):717-23. PubMed ID: 11046110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of intestinal absorption of an orally active beta-lactam prodrug: uptake and transport of carindacillin in Caco-2 cells.
    Li YH; Ito K; Tsuda Y; Kohda R; Yamada H; Itoh T
    J Pharmacol Exp Ther; 1999 Sep; 290(3):958-64. PubMed ID: 10454465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acids in the rat intestinal lumen regulate their own absorption from a distant intestinal site.
    Mourad FH; Barada KA; Khoury C; Hamdi T; Saadé NE; Nassar CF
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G292-8. PubMed ID: 19541927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased absorption of the antiviral ester prodrug tenofovir disoproxil in rat ileum by inhibiting its intestinal metabolism.
    Van Gelder J; Deferme S; Annaert P; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
    Drug Metab Dispos; 2000 Dec; 28(12):1394-6. PubMed ID: 11095573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal absorption of alpha-methyldopa: in vitro mechanistic studies in rat small intestinal segments.
    Osiecka I; Cortese M; Porter PA; Borchardt RT; Fix JA; Gardner CR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):443-9. PubMed ID: 3612544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-chain alkyl esters of L-dopa as prodrugs for rectal absorption.
    Fix JA; Alexander J; Cortese M; Engle K; Leppert P; Repta AJ
    Pharm Res; 1989 Jun; 6(6):501-5. PubMed ID: 2762226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of rat striatal L-dopa and DA concentration after intraperitoneal administration of L-dopa prodrugs in liposomal formulations.
    Di Stefano A; Carafa M; Sozio P; Pinnen F; Braghiroli D; Orlando G; Cannazza G; Ricciutelli M; Marianecci C; Santucci E
    J Control Release; 2004 Sep; 99(2):293-300. PubMed ID: 15380638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.